Enterprise League logo
CiceroDiagnostics, Inc. Logo

CiceroDiagnostics, Inc.

Henderson, United States (US) · Health and Medical

We built this page from public sources. What we do with your data

Do you work at CiceroDiagnostics, Inc.?

Claim this profile to manage your company.

Verified by Enterprise League

Data quality

Complete · Accuracy

CiceroDiagnostics, Inc. is a Health and Medical company based in Henderson, United States (US), founded in 2015, with 2-10 employees. CiceroDiagnostics, Inc.'s profile is verified on Enterprise League.

Overview

CiceroDiagnostics, Inc. is a leading diagnostics company dedicated to improving patient outcomes in fertility and reproductive health. Based in Henderson, Nevada, we specialize in providing innovative clinical assays for the early detection of endometriosis, a condition affecting over 176 million women worldwide. Our ReceptivaDx test represents a new generation of testing, offering a reliable and less invasive method to identify BCL6, a key marker associated with endometriosis and its impact on fertility. By expediting patient referrals to endometriosis specialists and facilitating targeted treatment plans, Cicero Diagnostics empowers healthcare providers to significantly improve the chances of successful pregnancies for their patients. Supported by extensive clinical data and ongoing research collaborations with leading academic institutions, we are committed to advancing the understanding and treatment of endometriosis and related reproductive challenges.
Visit Official Website

Most teams do this before shortlisting


Contact Details

cjackson@cicerodx.com

Henderson, United States (US), 2538 Anthem Village Drive

Founded

2015

Company Type

Private Limited Company

Employees

2-10

Categories

Medical Equipment and Services
Healthcare
Hospital

Awards

• 2026 OpenSee all

Services

Default Product Image
ReceptivaDx™
Healthcare

ReceptivaDx is a biochemical test designed to detect BCL6, a key marker associated with endometriosis, in endometrial biopsies. It helps identify women with unexplained infertility, failed IVF, and recurrent pregnancy loss, enabling earlier diagnosis and treatment. The test offers a high sensitivity and specificity (93% and 96% respectively) and provides a valuable tool for fertility specialists.

N/A

Companies teams usually look at after CiceroDiagnostics, Inc.

Comparing a few options usually leads to better decisions






  • Save companies to compare later. Useful when sharing options with your team

This is how your company profile looks to others.